Bill · H.Res. 685· House(119-HRES-685)

Expressing support for testing for antiphospholipid syndrome (APS) as a standard part of prenatal screening, and for other purposes.

Age: 38 years

Florida

Introduced: 9/9/2025
Last activity: 9/9/2025 — Referred to the House Committee on Energy and Commerce.
Sponsored by: Kat Cammack
Cosponsors: - 3 - 5

Health

Introduced
In Committee

A House resolution is the House speaking for itself: stating a position, honouring someone, or setting its own rules. Adopting it is the whole process. Once the House agrees to it, it is officially the House's word; it is not a law, so the Senate and the President have no part in it.

What this bill would do

This resolution expresses support for testing for antiphospholipid syndrome (APS) as a standard part of prenatal screening. APS is a condition where the immune system produces antibodies that increase blood clot risks. These risks can lead to miscarriages, stillbirths, and other pregnancy complications. Currently, medical guidelines only recommend testing after specific unexplained losses have occurred. The resolution calls for testing during normal prenatal screening to potentially save babies and reduce grief. It also asks medical associations to update their official recommendations to include this testing.

Yes

Would women be better off under this?+7
The resolution seeks to reduce pregnancy complications, miscarriages, and grief experienced by women through standard APS testing.
Would children be better off under this?+6
Early detection and treatment of APS during prenatal screening can help prevent stillbirths and save babies.
Does this make health care easier to get in general?+5
The resolution encourages early detection of APS through standard prenatal screening to facilitate timely medical intervention.